Ludger Ltd

The team of specialists at Ludger can provide glycoprofiling services and technology to help you engineer, optimise, measure and control the glycosylation of your therapeutic glycoprotein product. Established in 1999 we have a wealth of experience providing structural glycan characterisation of innovator and biosimilar biotherapeutics, including:

Monoclonal antibodies (mAbs)
Hormones e.g erythropoeitin (EPO)
Fc fusion proteins
Plant glycoproteins
Viral glycoproteins
Parasitic glycoproteins
Vaccines
Clotting factors

This will help you address safety, efficacy, product consistency, stability and half-life, regulatory compliance, patent issues and comparability of your drugs. Analytical methods used in house include (U)HPLC, ESI-MS, MALDI-MS, LC-MS. In addition we can work to Good Manufacturing Practice (GMP) level services for our clients